| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.341 | |
| cellular response to interleukin 4 | GO:0071353 | 21 | 0.273 | |
| regulation of protein transport | GO:0051223 | 163 | 0.230 | |
| dna repair | GO:0006281 | 107 | 0.206 | |
| intracellular protein transport | GO:0006886 | 204 | 0.168 | |
| negative regulation of cell size | GO:0045792 | 3 | 0.147 | |
| camera type eye development | GO:0043010 | 266 | 0.144 | |
| protein targeting | GO:0006605 | 143 | 0.144 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.135 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.135 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.121 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.119 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.119 | |
| organelle assembly | GO:0070925 | 177 | 0.117 | |
| transmembrane transport | GO:0055085 | 412 | 0.115 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.108 | |
| single organism nuclear import | GO:1902593 | 95 | 0.107 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.106 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.101 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.098 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.098 | |
| protein secretion | GO:0009306 | 111 | 0.089 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.083 | |
| regulation of protein localization | GO:0032880 | 231 | 0.083 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.078 | |
| cation transport | GO:0006812 | 399 | 0.078 | |
| gene silencing | GO:0016458 | 38 | 0.073 | |
| response to amino acid | GO:0043200 | 37 | 0.068 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.065 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.059 | |
| cardiac muscle cell development | GO:0055013 | 39 | 0.058 | |
| hexose catabolic process | GO:0019320 | 3 | 0.058 | |
| lipid particle organization | GO:0034389 | 7 | 0.057 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.057 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.056 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.055 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.053 | |
| spindle assembly | GO:0051225 | 13 | 0.051 | |
| chromatin organization | GO:0006325 | 206 | 0.050 | |
| retina homeostasis | GO:0001895 | 23 | 0.048 | |
| chromatin modification | GO:0016568 | 187 | 0.047 | |
| wound healing | GO:0042060 | 157 | 0.047 | |
| nadph regeneration | GO:0006740 | 2 | 0.046 | |
| oxidation reduction process | GO:0055114 | 342 | 0.045 | |
| ear development | GO:0043583 | 200 | 0.044 | |
| transcription coupled nucleotide excision repair | GO:0006283 | 2 | 0.043 | |
| actin filament based movement | GO:0030048 | 23 | 0.043 | |
| positive regulation of viral genome replication | GO:0045070 | 2 | 0.043 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.042 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.041 | |
| protein localization to organelle | GO:0033365 | 185 | 0.041 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.041 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.041 | |
| regulation of transporter activity | GO:0032409 | 57 | 0.040 | |
| protein import | GO:0017038 | 101 | 0.039 | |
| protein ubiquitination | GO:0016567 | 171 | 0.039 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.038 | |
| telencephalon development | GO:0021537 | 186 | 0.038 | |
| blood circulation | GO:0008015 | 195 | 0.038 | |
| cofactor metabolic process | GO:0051186 | 80 | 0.036 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.036 | |
| protein depolymerization | GO:0051261 | 34 | 0.036 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.036 | |
| protein catabolic process | GO:0030163 | 221 | 0.036 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.035 | |
| cranial nerve formation | GO:0021603 | 4 | 0.035 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.035 | |
| posttranscriptional gene silencing | GO:0016441 | 10 | 0.034 | |
| blood coagulation | GO:0007596 | 76 | 0.034 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.033 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.033 | |
| rna interference | GO:0016246 | 2 | 0.032 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.032 | |
| chronological cell aging | GO:0001300 | 1 | 0.032 | |
| spindle organization | GO:0007051 | 28 | 0.032 | |
| regulation of secretion | GO:0051046 | 274 | 0.032 | |
| receptor mediated endocytosis | GO:0006898 | 51 | 0.032 | |
| substantia nigra development | GO:0021762 | 2 | 0.031 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.031 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.029 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.029 | |
| response to oxidative stress | GO:0006979 | 123 | 0.029 | |
| muscle system process | GO:0003012 | 141 | 0.029 | |
| viral process | GO:0016032 | 41 | 0.029 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.029 | |
| gene silencing by rna | GO:0031047 | 19 | 0.028 | |
| negative regulation of purine nucleotide catabolic process | GO:0033122 | 9 | 0.028 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.028 | |
| glucose catabolic process | GO:0006007 | 3 | 0.027 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.027 | |
| thermosensory behavior | GO:0040040 | 1 | 0.027 | |
| circulatory system process | GO:0003013 | 197 | 0.027 | |
| response to interleukin 4 | GO:0070670 | 23 | 0.027 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.027 | |
| cytoskeleton dependent intracellular transport | GO:0030705 | 50 | 0.027 | |
| atp catabolic process | GO:0006200 | 55 | 0.027 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.027 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.027 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.026 | |
| recombinational repair | GO:0000725 | 21 | 0.026 | |
| mesenchyme development | GO:0060485 | 152 | 0.026 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.026 | |
| vasoconstriction | GO:0042310 | 27 | 0.026 | |
| dna metabolic process | GO:0006259 | 303 | 0.026 | |
| microtubule based transport | GO:0010970 | 50 | 0.026 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.025 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.025 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.025 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.025 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.025 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.025 | |
| dna hypermethylation | GO:0044026 | 3 | 0.025 | |
| regulation of nucleocytoplasmic transport | GO:0046822 | 73 | 0.024 | |
| actin mediated cell contraction | GO:0070252 | 15 | 0.024 | |
| heart morphogenesis | GO:0003007 | 178 | 0.024 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.024 | |
| actin filament organization | GO:0007015 | 113 | 0.024 | |
| regulation of symbiosis encompassing mutualism through parasitism | GO:0043903 | 52 | 0.024 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.024 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.024 | |
| smooth muscle contraction | GO:0006939 | 44 | 0.024 | |
| nuclear import | GO:0051170 | 95 | 0.024 | |
| intermediate filament bundle assembly | GO:0045110 | 3 | 0.024 | |
| epidermis development | GO:0008544 | 187 | 0.024 | |
| internal protein amino acid acetylation | GO:0006475 | 42 | 0.023 | |
| stem cell proliferation | GO:0072089 | 117 | 0.023 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.023 | |
| positive regulation of intracellular protein transport | GO:0090316 | 42 | 0.023 | |
| urogenital system development | GO:0001655 | 261 | 0.023 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.023 | |
| histone acetylation | GO:0016573 | 41 | 0.023 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.023 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.022 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.022 | |
| hemostasis | GO:0007599 | 78 | 0.022 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.022 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.022 | |
| peptidyl proline modification | GO:0018208 | 6 | 0.022 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.021 | |
| meiosis i | GO:0007127 | 60 | 0.021 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.021 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.021 | |
| stem cell development | GO:0048864 | 219 | 0.021 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.021 | |
| asymmetric neuroblast division | GO:0055059 | 1 | 0.021 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.021 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.021 | |
| internal peptidyl lysine acetylation | GO:0018393 | 42 | 0.021 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.021 | |
| positive regulation of protein secretion | GO:0050714 | 52 | 0.020 | |
| myotube differentiation | GO:0014902 | 105 | 0.020 | |
| dna dealkylation | GO:0035510 | 11 | 0.020 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.020 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.020 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.020 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.020 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.020 | |
| multicellular organism growth | GO:0035264 | 161 | 0.020 | |
| coagulation | GO:0050817 | 78 | 0.020 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.020 | |
| skeletal myofibril assembly | GO:0014866 | 4 | 0.020 | |
| anion transport | GO:0006820 | 177 | 0.020 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.020 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.020 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.020 | |
| regulation of tube size | GO:0035150 | 57 | 0.020 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.020 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.020 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.020 | |
| telomere maintenance via telomerase | GO:0007004 | 1 | 0.019 | |
| chemotaxis | GO:0006935 | 247 | 0.019 | |
| pentose phosphate shunt | GO:0006098 | 2 | 0.019 | |
| negative regulation of oxidative stress induced intrinsic apoptotic signaling pathway | GO:1902176 | 4 | 0.019 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.019 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.019 | |
| protein import into nucleus | GO:0006606 | 95 | 0.019 | |
| intrahepatic bile duct development | GO:0035622 | 2 | 0.019 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.018 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.018 | |
| tissue homeostasis | GO:0001894 | 115 | 0.018 | |
| dna modification | GO:0006304 | 50 | 0.018 | |
| photoreceptor cell development | GO:0042461 | 40 | 0.018 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.018 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.018 | |
| axon guidance | GO:0007411 | 141 | 0.018 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.017 | |
| cellular protein complex disassembly | GO:0043624 | 36 | 0.017 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.017 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.017 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.017 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.017 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.017 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.017 | |
| calcium ion transport | GO:0006816 | 159 | 0.017 | |
| posttranscriptional gene silencing by rna | GO:0035194 | 10 | 0.017 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.017 | |
| neural tube development | GO:0021915 | 160 | 0.017 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.017 | |
| calcium ion transmembrane transport | GO:0070588 | 85 | 0.016 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.016 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.016 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.016 | |
| response to inorganic substance | GO:0010035 | 96 | 0.016 | |
| negative regulation of chromatin silencing | GO:0031936 | 1 | 0.016 | |
| heart contraction | GO:0060047 | 93 | 0.016 | |
| response to acid chemical | GO:0001101 | 111 | 0.016 | |
| positive regulation of mrna metabolic process | GO:1903313 | 17 | 0.016 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.016 | |
| neural tube formation | GO:0001841 | 108 | 0.016 | |
| cyclic nucleotide metabolic process | GO:0009187 | 59 | 0.016 | |
| skeletal muscle thin filament assembly | GO:0030240 | 2 | 0.016 | |
| positive regulation of heart rate by epinephrine norepinephrine | GO:0001996 | 4 | 0.016 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.016 | |
| digestive system development | GO:0055123 | 200 | 0.016 | |
| regulation of ubiquitin protein ligase activity involved in mitotic cell cycle | GO:0051439 | 1 | 0.015 | |
| kidney development | GO:0001822 | 213 | 0.015 | |
| dendritic spine morphogenesis | GO:0060997 | 22 | 0.015 | |
| placenta development | GO:0001890 | 140 | 0.015 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.015 | |
| meiotic cell cycle process | GO:1903046 | 77 | 0.015 | |
| regulation of immunological synapse formation | GO:2000520 | 2 | 0.015 | |
| endocytosis | GO:0006897 | 168 | 0.015 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.015 | |
| cranial nerve morphogenesis | GO:0021602 | 26 | 0.015 | |
| cellular response to lipid | GO:0071396 | 145 | 0.015 | |
| amine metabolic process | GO:0009308 | 45 | 0.015 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.015 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.015 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.015 | |
| muscle fiber development | GO:0048747 | 76 | 0.015 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.015 | |
| positive regulation of protein export from nucleus | GO:0046827 | 4 | 0.015 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.015 | |
| tube formation | GO:0035148 | 140 | 0.015 | |
| coenzyme metabolic process | GO:0006732 | 52 | 0.015 | |
| regulation of cell activation | GO:0050865 | 289 | 0.015 | |
| positive regulation of dna templated transcription elongation | GO:0032786 | 2 | 0.015 | |
| cell chemotaxis | GO:0060326 | 81 | 0.015 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.014 | |
| mitotic cytokinesis | GO:0000281 | 4 | 0.014 | |
| nerve development | GO:0021675 | 67 | 0.014 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.014 | |
| photoreceptor cell differentiation | GO:0046530 | 52 | 0.014 | |
| response to metal ion | GO:0010038 | 47 | 0.014 | |
| digestive tract development | GO:0048565 | 190 | 0.014 | |
| muscle tissue development | GO:0060537 | 308 | 0.014 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.014 | |
| regulation of transcription by chromatin organization | GO:0034401 | 0 | 0.014 | |
| epithelial cell development | GO:0002064 | 159 | 0.014 | |
| alpha amino acid metabolic process | GO:1901605 | 59 | 0.014 | |
| viral life cycle | GO:0019058 | 36 | 0.014 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.014 | |
| cell cell recognition | GO:0009988 | 44 | 0.014 | |
| leukocyte migration | GO:0050900 | 124 | 0.014 | |
| cranial nerve development | GO:0021545 | 41 | 0.014 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.014 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.014 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.014 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.014 | |
| vascular smooth muscle contraction | GO:0014829 | 5 | 0.014 | |
| regulation of ion transport | GO:0043269 | 215 | 0.014 | |
| synaptonemal complex organization | GO:0070193 | 15 | 0.014 | |
| positive regulation of actin filament depolymerization | GO:0030836 | 5 | 0.014 | |
| cilium morphogenesis | GO:0060271 | 102 | 0.013 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.013 | |
| cofactor biosynthetic process | GO:0051188 | 41 | 0.013 | |
| epithelial tube formation | GO:0072175 | 130 | 0.013 | |
| negative regulation of t cell activation | GO:0050868 | 65 | 0.013 | |
| extracellular structure organization | GO:0043062 | 148 | 0.013 | |
| peptidyl lysine acetylation | GO:0018394 | 45 | 0.013 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.013 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.013 | |
| cell recognition | GO:0008037 | 83 | 0.013 | |
| regulation of protein targeting | GO:1903533 | 61 | 0.013 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.013 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.013 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.013 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.013 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.013 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.013 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.013 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.013 | |
| protein dna complex subunit organization | GO:0071824 | 28 | 0.013 | |
| mapk cascade | GO:0000165 | 281 | 0.013 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.013 | |
| positive regulation of actin nucleation | GO:0051127 | 3 | 0.013 | |
| histone modification | GO:0016570 | 159 | 0.013 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.012 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.012 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.012 | |
| positive regulation of atpase activity | GO:0032781 | 3 | 0.012 | |
| stem cell differentiation | GO:0048863 | 268 | 0.012 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.012 | |
| rna dependent dna replication | GO:0006278 | 3 | 0.012 | |
| response to growth factor | GO:0070848 | 198 | 0.012 | |
| sensory perception | GO:0007600 | 245 | 0.012 | |
| regulation of calcium ion transmembrane transport | GO:1903169 | 20 | 0.012 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.012 | |
| actin polymerization or depolymerization | GO:0008154 | 54 | 0.012 | |
| morphogenesis of a polarized epithelium | GO:0001738 | 37 | 0.012 | |
| microtubule based process | GO:0007017 | 236 | 0.012 | |
| neuroblast proliferation | GO:0007405 | 49 | 0.012 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.012 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.012 | |
| fertilization | GO:0009566 | 127 | 0.012 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.012 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.012 | |
| ear morphogenesis | GO:0042471 | 118 | 0.012 | |
| response to amine | GO:0014075 | 16 | 0.012 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.012 | |
| response to testosterone | GO:0033574 | 3 | 0.012 | |
| myotube cell development | GO:0014904 | 60 | 0.012 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.011 | |
| organelle localization | GO:0051640 | 179 | 0.011 | |
| cell maturation | GO:0048469 | 127 | 0.011 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.011 | |
| neural retina development | GO:0003407 | 41 | 0.011 | |
| dendrite development | GO:0016358 | 115 | 0.011 | |
| positive regulation of cardiac muscle contraction | GO:0060452 | 2 | 0.011 | |
| membrane organization | GO:0061024 | 245 | 0.011 | |
| pancreas development | GO:0031016 | 57 | 0.011 | |
| dna replication | GO:0006260 | 52 | 0.011 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.011 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.011 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.011 | |
| skin development | GO:0043588 | 220 | 0.011 | |
| positive regulation of reactive oxygen species biosynthetic process | GO:1903428 | 2 | 0.011 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.011 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.011 | |
| regulation of system process | GO:0044057 | 200 | 0.011 | |
| chromatin remodeling | GO:0006338 | 32 | 0.011 | |
| connective tissue development | GO:0061448 | 179 | 0.011 | |
| regulation of protein import into nucleus translocation | GO:0033158 | 2 | 0.011 | |
| negative regulation of intracellular transport | GO:0032387 | 38 | 0.011 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.011 | |
| positive regulation of intracellular transport | GO:0032388 | 70 | 0.011 | |
| neuron projection guidance | GO:0097485 | 141 | 0.011 | |
| positive regulation of rna splicing | GO:0033120 | 12 | 0.011 | |
| cellular homeostasis | GO:0019725 | 240 | 0.011 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.011 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.011 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.011 | |
| protein sumoylation | GO:0016925 | 14 | 0.011 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.011 | |
| positive regulation of viral process | GO:0048524 | 5 | 0.011 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.011 | |
| nuclear transport | GO:0051169 | 139 | 0.011 | |
| spindle assembly involved in female meiosis | GO:0007056 | 3 | 0.011 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.010 | |
| translesion synthesis | GO:0019985 | 1 | 0.010 | |
| optic nerve morphogenesis | GO:0021631 | 6 | 0.010 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 55 | 0.010 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.010 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.010 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.010 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.010 | |
| hindbrain development | GO:0030902 | 128 | 0.010 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.010 | |
| response to increased oxygen levels | GO:0036296 | 2 | 0.010 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.010 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.010 | |
| organic acid transport | GO:0015849 | 101 | 0.010 | |
| regulation of neuron death | GO:1901214 | 134 | 0.010 | |
| mitochondrion organization | GO:0007005 | 134 | 0.010 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.010 | |
| cell adhesion | GO:0007155 | 329 | 0.010 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.010 | |
